Proinflammatory cytokines expressed by primary breast tumors activate an IL-1β-dependent innate immune response in innate immune cells infiltrating the microenvironment of distant metastasis-initiating cancer cells (MICs), which may prevent the development of secondary disease and, conversely, primary tumor resection may prompt recurrence [93]. Here, IL1B is linked to cancer.